Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
SER holding history
Serina Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SER overviewAll 13F holders of SERFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −13,184−100.0% | Sold out | Holders |
| Q1 2025 | 13,184 | $74.8K | <0.1% | +13,184 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −613−100.0% | Sold outConverted for a 1-for-35 split | Holders |
| Q4 2023 | 21,448 | $8.26K | <0.1% | +21,448 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −10,702−100.0% | Sold out | Holders |
| Q2 2023 | 10,702 | $9.56K | <0.1% | −2,719−20.3% | Reduced | Holders |
| Q1 2023 | 13,421 | $8.90K | <0.1% | +13,421 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −10,029−100.0% | Sold out | Holders |
| Q3 2022 | 10,029 | $6.00K | <0.1% | −5,988−37.4% | Reduced | Holders |
| Q2 2022 | 16,017 | $9.00K | <0.1% | +16,017 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −40,537−100.0% | Sold out | Holders |
| Q3 2021 | 40,537 | $38.0K | <0.1% | +40,537 | New | Holders |